Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK3277511A in COPD patients
NCT03281876Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2017
- Primary completion
- Mar 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 8
01
Overview
A Phase 2 trial of GSK3277511A in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Nov 2017; status: completed.
02
Drugs
GSK3277511A
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03281876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03281876.